Business Wire

TX-MARY-KAY

31.3.2021 15:02:06 CEST | Business Wire | Press release

Share
Global Youth Problem-Solvers Announced as Winners of Mary Kay Inc.-Sponsored NFTE World Series of Innovation Challenge

Mary Kay Inc., a leading corporate advocate of women’s empowerment and entrepreneurship, announced today the top three winners of its World Series of Innovation (WSI) Challenge in partnership with the Network for Teaching Entrepreneurship (NFTE). In its first year partnering with NFTE, Mary Kay sponsored the 2020 NFTE World Series of Innovation, a global educational experience that invites young people ages 13-24 to channel their critical thinking and problem-solving skills to find solutions for the biggest challenges facing the world today and help advance the UN Sustainable Development Goals (SDGs) while fostering an entrepreneurial mindset.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210331005187/en/

Mary Kay’s World Series of Innovation Challenge encouraged young people from around the world to submit innovative solutions to address Sustainable Development Goal 12: Responsible Consumption and Production . Globally, it is estimated that 80% of discarded textiles wind up in landfills. That statistic earns the clothing and textiles industry the #2 spot on the list of worst-polluting industries, second only to the petrochemical industry. For this challenge, students were asked to design a product, service or initiative that will create a “circular economy” that encourages the reuse or repurposing of uniforms and/or other used clothing, reducing waste that ends up in landfills and decreasing greenhouse gas emissions from decomposing textiles.

The three winners of Mary Kay’s Challenge are:

  • First Place: Loop Tee Loop
    • Loop Tee Loop is a sustainable clothing loop uniting lyocell textile mills with uniform recycling collection services from Metro Manila in the Philippines.
  • Second Place: SwagSwap
    • SwagSwap is a US-based social network for thrifting, enabling peer-to-peer clothing swap for teens.
  • Third Place: Project DBrand
    • Project DBrand is a unique service that de-brands used uniforms so they can be upcycled based in the US.

“Students today grow up in a world where sustainability is part of the daily, global conversation and they are actively engaged to drive change,” said Deborah Gibbins, Chief Operating Officer at Mary Kay Inc. “Mary Kay is proud to partner with NFTE, an organization that is helping to not only ignite the entrepreneurial mindset in youth, but is encouraging them to think critically to tackle challenging global issues. Global companies like Mary Kay have a responsibility to foster entrepreneurial innovation that can help to make the world a better place.”

NFTE is a global educational nonprofit focused on bringing the power of entrepreneurship to youth in low-income communities. The World Series of Innovation (WSI) Challenge invites corporate sponsored challenges to address the UN Sustainable Development Goals. With a reach of 100,000 students worldwide, in 2020 NFTE received nearly 4,000 student participants of all backgrounds submitting ideas in the WSI Challenges and nearly 350 students participated in the Mary Kay-sponsored challenge.

“The World Series of Innovation encourages young people to apply their entrepreneurial mindset to address global challenges,” said J.D. LaRock, President and Chief Executive Officer of NFTE. “Each year, we continue to be inspired by the innovative ideas the next generation of entrepreneurs envision. We are grateful to Mary Kay Inc. for posing this thought-provoking global challenge that encouraged students to think about the circular economy of clothing and textiles in a whole new way.”

In addition to the World Series of Innovation, Mary Kay was one of the lead sponsors of the 2020 NFTE’s United Nations Global Goals Conversation, an annual thought leadership event convening youth, industry, nonprofits, and philanthropy to advance a dialogue around social entrepreneurship solutions. Held during Global Entrepreneurship Week, the topic of the panel was “Engaging entrepreneurs to innovate and take action using technology as a tool for social good. ” The panelists discussed innovative ways to use technology to emerge from the challenges raised by pandemic such as unemployment, economic recession and an increasing social unrest to build a more equitable and inclusive society in a post-COVID world. The 2020 UN Global Goals Conversation was presented by Citi Foundation, Ernst & Young LLP (EY) and Mary Kay Inc., with additional support from Bank of the West BNP Paribas.

For more information about the World Series of Innovation and all challenges, visit https://innovation.nfte.com .

About Mary Kay
One of the original glass ceiling breakers, Mary Kay Ash founded her beauty company nearly 60 years ago with three goals: develop rewarding opportunities for women, offer irresistible products, and make the world a better place. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skin care, color cosmetics, nutritional supplements and fragrances. Mary Kay is committed to empowering women and their families by partnering with organizations from around the world, focusing on supporting cancer research, protecting survivors from domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Mary Kay Ash’s original vision continues to shine—one lipstick at a time.

About NFTE
Network for Teaching Entrepreneurship (NFTE) is a global nonprofit organization that provides high-quality entrepreneurship education to middle and high school students from under-resourced communities, as well as programs for college students and adults. NFTE reaches 70,000+ students annually in 25 states across the U.S. and offers programs in 12 additional countries. We have educated more than a million students through in-school, out-of-school, college, and summer camp programs, offered in person and online. To learn more about how we are promoting inclusive capitalism and building the next generation of diverse entrepreneurs, visit www.nfte.com .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye